Mahathir Bayena

Northern Minerals (ASX:NTU) announced that the Federal Treasurer has issued new disposal orders targeting a block of the company’s equity.

Oobit officially launched its crypto payments platform in Colombia, marking the company’s ninth active market as it expands further across Latin America.

Australian oil and gas explorer Condor Energy (ASX:CND) has formalised its ongoing exploration and corporate strategy.

Intesa Sanpaolo more than doubled its cryptocurrency exposure during the first quarter of 2026, increasing holdings from around $100 million at the end of 2025 to approximately $235 million by March 31, according to a report from Criptovaluta.it.

CervoMed (NASDAQ:CRVO) reported its financial results for the first quarter of 2026, alongside corporate and clinical milestones for its lead oral small-molecule drug candidate, neflamapimod.

AFT Pharmaceuticals (ASX:AFP) announced the appointment of Stuart Houliston as its new CFO, effective June 15.

Philips (NYSE:PHG), in partnership with healthcare technology firms Cuviva and Vingmed, has been selected by Region Stockholm to implement a large-scale hospital-at-home program.

RenX Enterprises (NASDAQ:RENX) reported strong sequential revenue expansion for the first quarter of 2026, driven by higher utilization across its contracted hauling agreements and accelerating bulk material sales, even as advanced technology integration costs left consolidated bottom-line metrics in a deficit.

BioXcel Therapeutics (NASDAQ:BTAI) announced that the U.S. Food and Drug Administration has formally accepted a supplemental New Drug Application for its lead neuropsychiatric drug, providing a clear regulatory catalyst as the company manages tightening capital constraints.

Purple Biotech (NASDAQ:PPBT) reported its financial and operational results for the first quarter of 2026, highlighting clinical milestones within its immunotherapy pipeline and a stabilized bottom line supported by non-operating income.